Swiss National Bank 23and Me Holding Co. Transaction History

Swiss National Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.71 - $0.97 $27,619 - $37,733	-38,900 Reduced 6.71%	540,900 $492,000
Q3 2023 Nov 08, 2023	BUY	$0.96 - $2.01 $13,440 - $28,139	14,000 Added 2.47%	579,800 $568,000
Q2 2023 Aug 09, 2023	SELL	$1.59 - $2.29 $35,298 - $50,838	-22,200 Reduced 3.78%	565,800 $990,000
Q1 2023 May 10, 2023	SELL	$2.05 - $2.87 $15,989 - $22,386	-7,800 Reduced 1.31%	588,000 $1.34 Million
Q4 2022 Feb 08, 2023	BUY	$2.06 - $3.47 $25,544 - $43,028	12,400 Added 2.13%	595,800 $1.29 Million
Q3 2022 Nov 09, 2022	BUY	$2.6 - $5.12 $547,040 - $1.08 Million	210,400 Added 56.41%	583,400 $1.67 Million
Q2 2022 Aug 09, 2022	BUY	$2.19 - $3.98 $336,384 - $611,328	153,600 Added 70.01%	373,000 $925,000
Q1 2022 May 09, 2022	BUY	$3.28 - $7.12 $283,064 - $614,456	86,300 Added 64.84%	219,400 $840,000
Q4 2021 Feb 08, 2022	BUY	$6.55 - $13.25 $871,805 - $1.76 Million	133,100 New	133,100 $886,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.